The companies BridgeBio, Erasca, Chai Discovery, and MeiraGTx bagged the biggest biotech funding rounds overall in July 2026.

About half of people with gout don't have treatments that work. Meet the new gout drugs racing through trials to reach them.

The only TIL therapy approved so far is Amtagvi for melanoma. Here are six companies with promising TIL therapies in the ...

We look at some of the top companies that are investigating CAR-T therapies in clinical trials for autoimmune diseases.

Delve into what Merck has planned for the future of its pipeline as Keytruda's patent is getting closer to expiry.

The biggest acquisition deal announced in June was by pharma giant AbbVie. Known for its monoclonal antibodies Humira and Skyrizi, for autoimmune diseases, AbbVie plans to buy Massachusetts-based ...

With a major restructuring underway, Japanese pharma giant Takeda is entering a defining period for its business. Having completed years of portfolio reshaping following its acquisition of Shire in ...

Bipolar disorder disrupts daily life, causing severe shifts in mood and energy, flipping between extreme highs and deep lows. Most patients who are prescribed currently available drugs for the ...

Roohi Mariam Peter has been a journalist at Labiotech since 2023. She writes news articles and in-depth features on healthcare, biopharma, science, fundraising, markets, and emerging therapies. She ...

Over the last decade, Poland has seen the rise of its biotech industry. While the country’s pharmaceutical industry has traditionally focused on developing generics, many of these companies have ...